Recurrent low-grade gliomas Clinical Trials

Delta Trials records 2 clinical trials for Recurrent low-grade gliomas in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 8 study locations around the world. An additional 1 trial are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.